PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 9 filers reported holding PRINCIPIA BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $296,325,000 | +0.8% | 4,956,097 | +0.1% | 0.03% | -19.5% |
| Q1 2020 | $294,006,000 | +9.1% | 4,951,265 | +0.7% | 0.04% | +36.7% |
| Q4 2019 | $269,405,000 | +165.3% | 4,917,932 | +36.8% | 0.03% | +150.0% |
| Q3 2019 | $101,539,000 | -14.5% | 3,595,562 | +0.4% | 0.01% | -14.3% |
| Q2 2019 | $118,819,000 | -2.4% | 3,579,968 | +0.0% | 0.01% | -6.7% |
| Q1 2019 | $121,713,000 | +289.1% | 3,579,788 | +213.4% | 0.02% | +275.0% |
| Q4 2018 | $31,281,000 | +51.0% | 1,142,071 | +61.1% | 0.00% | +100.0% |
| Q3 2018 | $20,713,000 | – | 708,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |